Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice.
Short-term early exposure to lapatinib confers lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice. J Exp Clin Cancer Res. 2017 01 06; 36(1):6.
View in:
PubMed
subject areas
Animals
Animals
Antineoplastic Agents
Antineoplastic Agents
Cell Line, Tumor
Cell Line, Tumor
Cell Proliferation
Cell Proliferation
Drug Administration Schedule
Drug Administration Schedule
ErbB Receptors
ErbB Receptors
Female
Female
Gene Expression Regulation, Neoplastic
Gene Expression Regulation, Neoplastic
Humans
Humans
Mammary Neoplasms, Experimental
Mammary Neoplasms, Experimental
Mice
Mice
Mice, Transgenic
Mice, Transgenic
Phosphorylation
Phosphorylation
Proto-Oncogene Proteins c-akt
Proto-Oncogene Proteins c-akt
Quinazolines
Quinazolines
Receptor, ErbB-2
Receptor, ErbB-2
Receptor, ErbB-3
Receptor, ErbB-3
authors with profiles
Stanley D Kosanke